🔎 Trials Near Me

Início › Câncer Colorretal › Flórida

Ensaios clínicos de Câncer Colorretal em Flórida

99 estudos para Câncer Colorretal estão buscando participantes em locais em Flórida.

Cidades em Flórida

Texto oficial do estudo (Inglês)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • e mais 6
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05673148

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • James A. Haley Veterans Hospital, Tampa
Recrutando
Idades de 65 a 82 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05612347

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
  • Advent Health, Orlando
  • Florida Cancer Specialists South, Port Charlotte
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

  • Mayo Clinic in Florida, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06265285

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • e mais 11
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Family Communications After Genetic Testing

  • Holy Cross Hospital, Fort Lauderdale
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07143487

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #48, Celebration
  • Exelixis Clinical Site #11, Gainesville
  • Exelixis Clinical Site #78, Jacksonville
  • e mais 2
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Moffitt Cancer Center, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Helios CR Inc, Lakeland
  • H. Lee Moffitt Cancer Center and Research Institute, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 7, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Jacksonville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  • Moffitt Cancer Center, Tampa
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07659795

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07578571

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • UF Health Cancer Institute - Gainesville, Gainesville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Florida Cancer Specialists, Bonita Springs
  • Florida Cancer Specialists, Bradenton
  • Comprehensive Hematology Oncology, Brandon
  • e mais 19
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  • University of Florida College of Medicine ( Site 0281), Gainesville
  • Mount Sinai Cancer Center ( Site 0287), Miami Beach
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06428409

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

  • GSK Investigational Site, Reunion
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07277270

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Jacksonville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Mayo Clinic Jacksonville, Jacksonville
  • Moffitt Cancer Center, Tampa
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

  • Florida Cancer Specialists, Sarasota
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06663319

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • Florida Cancer Specialists South, Fort Myers
  • AdventHealth Cancer Institute, Orlando
  • Florida Cancer Specialists North Region, St. Petersburg
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • Florida Cancer Specialists South, Fort Myers
  • AdventHealth Medical Group Oncology and Hematology at Orlando, Orlando
  • Florida Cancer Specialists North Region, St. Petersburg
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05863195

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • MDR Core Network, Boynton Beach
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  • Florida Cancer Specialists - East, Cape Coral
  • Florida Cancer Specialists - North, St. Petersburg
  • Moffitt Cancer Center, Tampa
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07221357

Precise Oncology Interventions in Nutrition and Training (OnPoint)

  • University of Miami, Miami
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06534918

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Florida Cancer Specialists, Sarasota
  • Moffitt Cancer Center and Research Institute, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Moffitt, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Mayo Clinic Cancer Center, Jacksonville
  • Moffitt Cancer Center, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Moffitt, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
  • Moffitt Cancer Center, Tampa
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07629960

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

  • Moffitt Cancer Center, Tampa
RecrutandoVoluntários saudáveis bem-vindos
Idades de 45 a 75 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06745895

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

  • Moffitt Cancer Center, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07487168

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Florida Oncology & Hematology, Fort Myers
  • University of Florida Health, Gainesville
  • Sylvester Comprehensive Cancer Center, Miami
  • e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07284849

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • Mayo Clinic in Florida, Jacksonville
  • Moffitt Cancer Center, Tampa
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT04929223

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  • Florida Cancer Specialists-Broadway, Fort Myers
  • Florida Cancer Specialists - St. Petersburg Bayfront, St. Petersburg
  • Florida Cancer Specialists East - FCS EAST - West Palm Beach, West Palm Beach
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07549412

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.